Antibiotic prescribing/respiratory tract infections Infections and Infestations
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: General practices will be included in the trial if: 1. They presently contribute up-to-standard data to CPRD 2. Consent to participation in the trial 3. Are located in areas that have given research governance approval for the study Data for non-trial CPRD practices will be eligible for observational data analysis to gauge the representativeness of practices and patients participating in the trial. Data for individual participants will be included if they are currently registered with CPRD general practices
Exclusion criteria
Exclusion criteria: No other exclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of antibiotic prescriptions for RTI per 1,000 registered patient years at 12 months follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Number of consultations for RTI with antibiotic prescribed / Total RTI consultations (%) at 12 months follow-up 2. Consultations and prescriptions as defined above during 14 days after the index consultation at 12 months follow-up 3. Number of consultations for RTI per 1,000 registered patient years 12 months follow-up 4. All antibiotic prescriptions per 1,000 registered patient years at 12 months follow-up 5. Number of hospital admission (by category) per 1,000 registered patient years at 12 months follow-up 6. Estimated costs of all health care utilisation per 1,000 registered patient years at 12 months follow-up 7. Broad categories of RTI subgroups including colds, sore throat, cough and bronchitis, otitis media and rhino-sinusitis (NICE, 2008) at 12 months follow-up 8. Number of adverse events ((peritonsillar abscess, mastoiditis, skin infections and bacterial infections) (by category) per 1,000 registered patient years over at 12-months follow-up | — |
Countries
United Kingdom